Annual total expenses:
$29.34B+$854.95M(+3.00%)Summary
- As of today (August 16, 2025), TAK annual total expenses is $29.34 billion, with the most recent change of +$854.95 million (+3.00%) on March 1, 2025.
- During the last 3 years, TAK annual total expenses has fallen by -$368.37 million (-1.24%).
- TAK annual total expenses is now -1.74% below its all-time high of $29.86 billion, reached on March 31, 2020.
Performance
TAK Total expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly total expenses:
$6.38B-$82.49M(-1.28%)Summary
- As of today (August 16, 2025), TAK quarterly total expenses is $6.38 billion, with the most recent change of -$82.49 million (-1.28%) on June 1, 2025.
- Over the past year, TAK quarterly total expenses has dropped by -$305.84 million (-4.58%).
- TAK quarterly total expenses is now -19.69% below its all-time high of $7.94 billion, reached on December 31, 2023.
Performance
TAK Quarterly total expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Total expenses Formula
Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses
TAK Total expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +3.0% | -4.6% |
| 3 y3 years | -1.2% | +0.5% |
| 5 y5 years | -1.7% | +8.1% |
TAK Total expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -1.2% | +7.2% | -19.7% | +9.3% |
| 5 y | 5-year | -1.7% | +10.3% | -19.7% | +9.3% |
| alltime | all time | -1.7% | +538.9% | -19.7% | +379.9% |
TAK Total expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $6.38B(-1.3%) |
| Mar 2025 | $29.34B(+3.0%) | $6.46B(-15.6%) |
| Dec 2024 | - | $7.65B(+25.9%) |
| Sep 2024 | - | $6.08B(-9.1%) |
| Jun 2024 | - | $6.68B(+9.1%) |
| Mar 2024 | $28.49B(+4.1%) | $6.12B(-22.9%) |
| Dec 2023 | - | $7.94B(+5.0%) |
| Sep 2023 | - | $7.56B(+16.6%) |
| Jun 2023 | - | $6.49B(+11.2%) |
| Mar 2023 | $27.38B(-7.9%) | $5.83B(-13.4%) |
| Dec 2022 | - | $6.74B(+3.6%) |
| Sep 2022 | - | $6.50B(+2.5%) |
| Jun 2022 | - | $6.34B(-6.7%) |
| Mar 2022 | $29.71B(+11.7%) | $6.80B(-1.5%) |
| Dec 2021 | - | $6.90B(+1.7%) |
| Sep 2021 | - | $6.79B(+6.0%) |
| Jun 2021 | - | $6.40B(-4.7%) |
| Mar 2021 | $26.61B(-10.9%) | $6.72B(+1.1%) |
| Dec 2020 | - | $6.64B(-4.8%) |
| Sep 2020 | - | $6.98B(+18.3%) |
| Jun 2020 | - | $5.90B(-0.8%) |
| Mar 2020 | $29.86B(+68.8%) | $5.95B(-19.8%) |
| Dec 2019 | - | $7.41B(+6.4%) |
| Sep 2019 | - | $6.97B(-4.8%) |
| Jun 2019 | - | $7.31B(-0.5%) |
| Mar 2019 | $17.69B(+23.8%) | $7.35B(+114.1%) |
| Dec 2018 | - | $3.43B(+7.0%) |
| Sep 2018 | - | $3.21B(-0.3%) |
| Jun 2018 | - | $3.22B(-35.0%) |
| Mar 2018 | $14.29B(-4.3%) | $4.95B(+39.6%) |
| Dec 2017 | - | $3.54B(-0.2%) |
| Sep 2017 | - | $3.55B(+55.8%) |
| Jun 2017 | - | $2.28B(-51.6%) |
| Mar 2017 | $14.93B(+3.8%) | $4.71B(+25.5%) |
| Dec 2016 | - | $3.75B(-5.7%) |
| Sep 2016 | - | $3.98B(+53.0%) |
| Jun 2016 | - | $2.60B(-33.5%) |
| Mar 2016 | $14.38B(-17.9%) | $3.91B(+10.0%) |
| Dec 2015 | - | $3.56B(+9.5%) |
| Sep 2015 | - | $3.25B(-0.7%) |
| Jun 2015 | - | $3.27B(-49.1%) |
| Mar 2015 | $17.51B | $6.43B(+81.0%) |
| Dec 2014 | - | $3.55B(-4.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2014 | - | $3.73B(+9.5%) |
| Jun 2014 | - | $3.40B(-20.9%) |
| Mar 2014 | $15.82B(-6.9%) | $4.30B(+10.1%) |
| Dec 2013 | - | $3.90B(+5.7%) |
| Sep 2013 | - | $3.69B(+3.3%) |
| Jun 2013 | - | $3.58B(-27.4%) |
| Mar 2013 | $16.99B(-3.1%) | $4.93B(+11.1%) |
| Dec 2012 | - | $4.43B(+1.8%) |
| Sep 2012 | - | $4.36B(+4.0%) |
| Jun 2012 | - | $4.19B(-13.0%) |
| Mar 2012 | $17.54B(+28.2%) | $4.81B(+0.4%) |
| Dec 2011 | - | $4.80B(+5.1%) |
| Sep 2011 | - | $4.57B(+172.6%) |
| Jun 2011 | - | $1.67B(-78.0%) |
| Mar 2011 | $13.68B(+8.7%) | $7.63B(+320.3%) |
| Dec 2010 | - | $1.82B(+11.8%) |
| Sep 2010 | - | $1.62B(+10.5%) |
| Jun 2010 | - | $1.47B(-78.6%) |
| Mar 2010 | $12.58B(-3.0%) | $6.85B(+316.1%) |
| Dec 2009 | - | $1.65B(+10.1%) |
| Sep 2009 | - | $1.50B(+6.9%) |
| Jun 2009 | - | $1.40B(-79.3%) |
| Mar 2009 | $12.96B(+45.4%) | $6.77B(+409.5%) |
| Dec 2008 | - | $1.33B(-10.1%) |
| Sep 2008 | - | $1.48B |
| Mar 2008 | $8.92B(+7.6%) | - |
| Mar 2007 | $8.29B(+4.4%) | - |
| Mar 2006 | $7.94B(+1.0%) | - |
| Mar 2005 | $7.87B(+10.9%) | - |
| Mar 2004 | $7.09B(+11.6%) | - |
| Mar 2003 | $6.35B(+3.2%) | - |
| Mar 2002 | $6.16B(-16.6%) | - |
| Mar 2001 | $7.38B(+2.3%) | - |
| Mar 2000 | $7.22B(+21.8%) | - |
| Mar 1999 | $5.93B(-4.3%) | - |
| Mar 1998 | $6.19B(-8.9%) | - |
| Mar 1997 | $6.80B(-11.6%) | - |
| Mar 1996 | $7.69B(+5.0%) | - |
| Mar 1995 | $7.32B(+15.2%) | - |
| Mar 1994 | $6.36B(+17.3%) | - |
| Mar 1993 | $5.42B(+6.4%) | - |
| Mar 1992 | $5.10B(+10.9%) | - |
| Mar 1991 | $4.59B | - |
FAQ
- What is Takeda Pharmaceutical Company Limited annual total expenses?
- What is the all time high annual total expenses for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited annual total expenses year-on-year change?
- What is Takeda Pharmaceutical Company Limited quarterly total expenses?
- What is the all time high quarterly total expenses for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited quarterly total expenses year-on-year change?
What is Takeda Pharmaceutical Company Limited annual total expenses?
The current annual total expenses of TAK is $29.34B
What is the all time high annual total expenses for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high annual total expenses is $29.86B
What is Takeda Pharmaceutical Company Limited annual total expenses year-on-year change?
Over the past year, TAK annual total expenses has changed by +$854.95M (+3.00%)
What is Takeda Pharmaceutical Company Limited quarterly total expenses?
The current quarterly total expenses of TAK is $6.38B
What is the all time high quarterly total expenses for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high quarterly total expenses is $7.94B
What is Takeda Pharmaceutical Company Limited quarterly total expenses year-on-year change?
Over the past year, TAK quarterly total expenses has changed by -$305.84M (-4.58%)